英文别名3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 7-((hydroxydi-2-thienylacetyl)oxy)-9,9-dimethyl-, bromide, monohydrate, (1alpha,2beta,4beta,5alpha,7beta)-; Name: Tiotropium bromide hydrate; FC1259; (1a,2b,4b,5a,7b)-7-[(hydroxydi-2-thienylacety l)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide hydrate; (1?,2?,4?,5?,7?)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide hydrate; CS-2571; Spiriva; C19H22NO4S2.Br.H2O; Tiotropium bromide xhydrate; Tiotropium Bromide hydrate (BA679BR); Certified Reference Material; (1alpha,2beta,4beta,5alpha,7beta)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane bromide--water (1/1); BA-679-BR; AB01568260_01; 2759AH; 6beta,7beta-Epoxy-3beta-hydroxy-8-methyl-1alphaH,5alphaH-tropanium bromide, di-2-thienylglycolate; SCHEMBL155760; CT0199; CHEBI:32230; SCHEMBL1405692; MQLXPRBEAHBZTK-SEINRUQRSA-M; CHEMBL3545181; (1R,2R,4S,5S,7s)-7-(2-hydroxy-2,2-di(thiophen-2-yl)acetoxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide hydrate; AKOS015900631; SW219041-1; 411207-31-3; FT-0080433; BC220523; Tiotropium bromide monohydrate, European Pharmacopoeia (EP) Reference Standard; Tiotropium bromide hydrate; Tiotropium bromide monohydrate, >=98% (HPLC); 3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 7-((hydroxydi-2-thienylacetyl)oxy)-9,9-dimethyl-, bromide, hydrate, (1alpha,2beta,4beta,5alpha,7beta)-; G00011-Watson-Int; 139404-48-1; MFCD08141831; Tiotropium bromide monohydrate; 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-, bromide, hydrate, (1alpha,2beta,4beta,5alpha,7beta)- (9CI); ST24050179; HY-B0460; BCP02924; Tiotropium (bromide hydrate); Tiotropium fsystem suitability 1, European Pharmacopoeia (EP) Reference Standard; L64SXO195N; s2547; UNII-L64SXO195N; AK161935; Tiotropium Bromide Monohydrate, Pharmaceutical Secondary Standard; Tiotropium-Bromide-hydrate;收起